Notably, a reduction in GM-CSF concentrations within cystic fibrosis patients led to the hypothesis that this immunostimulatory factor may be responsible for the diminished immune response and increased susceptibility observed in this population [119]. The gene discussed is CSF2; the disease is cystic fibrosis.